FilingIndex
8-KThe WireRoutine

Shareholder Vote

Filed Apr 28, 2025 · 1y ago · Accession 0000078003-25-000109

Plain English

Material event — a significant development the company must disclose promptly.

Read the source below for the full document.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 24, 2025 PFIZER INC . (Exact name of registrant as specified in its charter) Delaware 1-3619 13-5315170 (State or other (Commission File (I.R.S. Employer jurisdiction of Number) Identification No.) incorporation)     66 Hudson Boulevard East 10001-2192 New York, New York (Zip Code) (Address of principal executive offices) Registrant’s telephone number, including area code: ( 212 ) 733-2323 (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.05 par value PFE New York Stock Exchange 1.000% Notes due 2027 PFE27 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company     ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.      ☐ Item 5.07 Submission of Matters to a Vote of Security Holders (a) The Pfizer Inc. (the "Company") Annual Meeting of Shareholders was held on April 24, 2025. (b) Shareholders voted on the matters set forth below. 1. The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 13, 2025 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following votes: Nominee Votes For       Votes Against Abstentions Broker non-vote Ronald E. Blaylock 3,429,698,773 137,851,886 13,621,435 954,654,621 Albert Bourla 3,246,800,234 307,245,700 27,123,033 954,654,621 Mortimer J. Buckley 3,465,158,857 102,427,543 13,584,534 954,654,621 Susan Desmond-Hellmann 3,448,290,762 117,666,670 15,212,701 954,654,621 Joseph J. Echevarria 3,173,957,929 393,321,228 13,891,403 954,654,621 Scott Gottlieb 3,500,030,435 69,733,819 11,402,546 954,654,621 Susan Hockfield 3,503,463,764 65,146,655 12,561,991 954,654,621 Dan R. Littman 3,411,026,726 156,668,049 13,478,088 954,654,621 Shantanu Narayen 3,485,062,345 82,853,611 13,251,147 954,654,621 Suzanne Nora Johnson 3,340,830,762 228,079,263 12,262,263 954,654,621 James Quincey 3,429,352,443 138,236,121 13,570,566 954,654,621 James C. Smith 3,341,701,230 226,092,580 13,378,736 954,654,621 Cyrus Taraporevala 3,462,368,536 105,107,798 13,690,897 954,654,621 2. The proposal to ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the 2025 fiscal year was approved based upon the following votes: Votes for approval 4,216,654,548 Votes against 300,423,270 Abstentions 18,745,406 Broker non-votes n/a 3. The proposal to approve, on an advisory basis, the 2025 compensation of the Company's Named Executive Officers was approved based upon the following votes: Votes for approval 1,947,064,397 Votes against 1,612,203,678 Abstentions 21,901,539 Broker non-votes 954,654,621 4. The shareholder proposal to Adopt Shareholder Vote Regarding Golden Parachutes was not approved based upon the following votes: Votes for approval 338,488,044 Votes against 3,208,877,595 Abstentions 33,777,457 Broker non-votes 954,654,621 5. The shareholder proposal to Issue A Report Evaluating The Risks Related To Religious Discrimination Against Employees was not approved based upon the following votes: Votes for approval 71,070,282 Votes against 3,448,108,236 Abstentions 61,979,369 Broker non-votes 954,654,621 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.   PFIZER INC.             Dated: April 28, 2025 By: /s/ Margaret M. Madden   Margaret M. Madden     Senior Vice President and Corporate Secretary     Chief Governance Counsel
Filing details
Company
PFIZER INC
Ticker
PFE
CIK
78003
Form type
8-K
Filing date
Apr 28, 2025
Report date
Apr 24, 2025
Document
pfe-20250424.htm
Size
220 KB